EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center

Kajetan Karaszewski iD, Jakub Góra, Monika Paluszewska, Elżbieta Urbanowska, Ewa Karakulska-Prystupiuk, Piotr Boguradzki, Agnieszka Tomaszewska, Grzegorz Władysław Basak, Wiesław Wiktor Jędrzejczak

Stem Cell Reviews and Reports · 2026-11 · 22 (8) · 3776-3789

DOI: 10.1007/s12015-026-11241-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reviews and Reports, online erschienen am 22.09.2026. Verfasst von Kajetan Karaszewski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Ul. Banacha 1A, 02-097, Warsaw, Poland. kajetan.karasz…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic hematopoietic cell transplantations (allo-HCT) is a procedure with long history and well-documented efficacy in treating various malignant and non-malignant diseases of the hematopoietic system. While there is a potential for late complications even over 10 years following allo-HCT, the data on longer observations are limited due to loss in follow-up, personnel and organizational changes in transplant centers, and focusing on new promising therapies instead of HCT. The study aimed to evaluate 15- and 20-year overall and progression-free survival of allo-HCT recipients in our center. During the inclusion period from 1999 to 2014, we identified 269 allo-HCT recipients. Survival analyses were performed using Kaplan-Meier curves, the Cox proportional hazards model, and the log-rank test. First, we evaluated 15- and 20-year survival rates for the entire cohort of allo-HCT recipients from matched related donor (MRD) and matched unrelated donor (MUD). Then we performed similar analyses for allo-HCT recipients due to acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), myelodysplastic neoplasms (MDS), non-Hodgkin lymphomas (NHL), and severe aplastic anemia (SAA). It was confirmed that survival benefit continues also during long-term observation. Notably, the plateau effect of PFS was often observed over 20 years following allo-HCT, implying the ability to cure in a relatively large group of patients with otherwise incurable diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHumansFemaleTransplantation, HomologousMaleAdolescentAdultMiddle AgedYoung AdultChildAgedMyelodysplastic Syndromes

Stichwörter der Autor:innen

Allogeneic transplantationBone marrow transplantationLong-term resultsOverall survivalProgression-free survival

Autor:innen und Institutionen

  • Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Ul. Banacha 1A, 02-097, Warsaw, Poland. kajetan.karaszewski@wum.edu.pl.
  • Doctoral School of the Medical University of Warsaw, Ul. Żwirki I Wigury 61, 02-091, Warsaw, Poland. kajetan.karaszewski@wum.edu.pl.
  • Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Ul. Banacha 1A, 02-097, Warsaw, Poland.

ORCID-Profile: Kajetan Karaszewski

Zitieren

APA

Karaszewski, K., Góra, J., Paluszewska, M., Urbanowska, E., Karakulska-Prystupiuk, E., Boguradzki, P., Tomaszewska, A., Basak, G. W., & Jędrzejczak, W. W. (2026). Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center. Stem Cell Reviews and Reports, 22(8), 3776-3789. https://doi.org/10.1007/s12015-026-11241-2

Vancouver

Karaszewski K, Góra J, Paluszewska M, Urbanowska E, Karakulska-Prystupiuk E, Boguradzki P, et al. Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center. Stem Cell Reviews and Reports. 2026;22(8):3776-3789. doi:10.1007/s12015-026-11241-2

BibTeX
@article{Karaszewski2026,
  author = {Karaszewski, Kajetan and Góra, Jakub and Paluszewska, Monika and Urbanowska, Elżbieta and Karakulska-Prystupiuk, Ewa and Boguradzki, Piotr and Tomaszewska, Agnieszka and Basak, Grzegorz Władysław and Jędrzejczak, Wiesław Wiktor},
  title = {Long-term Results of Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Real-life Data of 15- and 20-year Survivals from a Single Center},
  journal = {Stem Cell Reviews and Reports},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {3776--3789},
  doi = {10.1007/s12015-026-11241-2}
}
Kostenlos starten →